Selective 14-3-3γ induction quenches p-β-catenin Ser37/Bax-enhanced cell death in cerebral cortical neurons during ischemia

Cell Death and Disease

Volumn 5, Issue 4, 2014, Pages

  Lai, X J ^a   Ye, S Q ^a   Zheng, L ^a   Li, L ^a   Liu, Q R ^a   Yu, S B ^a   Pang, Y ^b   Jin, S ^a   Li, Q ^c   Yu, A C H ^b   Chen, X Q ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b PEKING UNIVERSITY   (China)

^c CHILDREN S HOSPITAL OF FUDAN UNIVERSITY   (China)

Author keywords

14 3 3; Astrocyte; Bax; Neuron; Stroke; catenin

Indexed keywords

APOPTOSIS SIGNAL REGULATING KINASE 1; BETA CATENIN; GLUCOSE; OXYGEN; PROTEIN 14 3 3; PROTEIN 14 3 3 GAMMA; PROTEIN BAD; PROTEIN BAX; PROTEIN P53; SERINE; UNCLASSIFIED DRUG; ISOPROTEIN; PHOSPHOSERINE; PROTEIN BINDING;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN ISCHEMIA; BRAIN NERVE CELL; CELL NUCLEUS; CELL SURVIVAL; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; DOWN REGULATION; EMBRYO; FLUORESCENCE MICROSCOPY; FLUORESCENCE RESONANCE ENERGY TRANSFER; IMMUNOPRECIPITATION; IN VIVO STUDY; MALE; MOUSE; NERVE CELL CULTURE; NERVE CELL NECROSIS; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; RAT; UPREGULATION; WESTERN BLOTTING; ANIMAL; BRAIN CORTEX; CELL CULTURE; CELL DEATH; CELL PROTECTION; DEFICIENCY; METABOLISM; NERVE CELL; PATHOLOGY; PHOSPHORYLATION; SPRAGUE DAWLEY RAT;

14-3-3 PROTEINS; ANIMALS; BCL-2-ASSOCIATED X PROTEIN; BETA CATENIN; BRAIN ISCHEMIA; CELL DEATH; CELL NUCLEUS; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CYTOPROTECTION; DOWN-REGULATION; GLUCOSE; MALE; MICE; NEURONS; OXYGEN; PHOSPHORYLATION; PHOSPHOSERINE; PROTEIN BINDING; PROTEIN ISOFORMS; RATS, SPRAGUE-DAWLEY; UP-REGULATION;

EID: 84900992992     PISSN: None     EISSN: 20414889     Source Type: Journal    
DOI: 10.1038/cddis.2014.152     Document Type: Article

References (46)

1. Adams Jr HP, del Zoppo G, Alberts MJ, Bhatt DL, Brass L, Furlan A et al. Guidelines for the early management of adults with ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council, Clinical Cardiology Council, Cardiovascular Radiology and Intervention Council, and the Atherosclerotic Peripheral Vascular Disease and Quality of Care Outcomes in Research Interdisciplinary Working Groups: The American Academy of Neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 2007; 115: e478-e534.
2. Lipton P. Ischemic cell death in brain neurons. Physiol Rev 1999; 79: 1431-1568.
3. Bederson JB, Pitts LH, Germano SM, Nishimura MC, Davis RL, Bartkowski HM. Evaluation of 2,3,5-triphenyltetrazolium chloride as a stain for detection and quantification of experimental cerebral infarction in rats. Stroke 1986; 17: 1304-1308.
4. Sandercock P, Wardlaw JM, Lindley RI, Dennis M, Cohen G, Murray G et al. The benefits and harms of intravenous thrombolysis with recombinant tissue plasminogen activator within 6 h of acute ischaemic stroke (the third international stroke trial [IST-3]): a randomised controlled trial. Lancet 2012; 379: 2352-2363.
5. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL et al. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet 2012; 379: 2364-2372.
6. Tissue plasminogen activator for acute ischemic stroke. The National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group. N Engl J Med 1995; 333: 1581-1587.
7. Fisher M. New approaches to neuroprotective drug development. Stroke 2011; 42(Suppl): S24-S27.
8. Stankowski JN, Gupta R. Therapeutic targets for neuroprotection in acute ischemic stroke: lost in translation? Antioxid Redox Signal 2011; 14: 1841-1851.
9. Faden AI, Stoica B. Neuroprotection: challenges and opportunities. Arch Neurol 2007; 64: 794-800.
10. Dong Y, Zhao R, Chen XQ, Yu AC. 14-3-3gamma and neuroglobin are new intrinsic protective factors for cerebral ischemia. Mol Neurobiol 2010; 41: 218-231.
11. Masters SC, Fu H. 14-3-3 proteins mediate an essential anti-apoptotic signal. J Biol Chem 2001; 276: 45193-45200.
12. Gelperin D, Weigle J, Nelson K, Roseboom P, Irie K, Matsumoto K et al. 14-3-3 proteins: potential roles in vesicular transport and Ras signaling in saccharomyces cerevisiae. Proc Natl Acad Sci USA 1995; 92: 11539-11543.
13. Li Z, Zhao J, Du Y, Park HR, Sun SY, Bernal-Mizrachi L et al. Down-regulation of 14-3-3zeta suppresses anchorage-independent growth of lung cancer cells through anoikis activation. Proc Natl Acad Sci USA 2008; 105: 162-167.
14. Morrison DK. The 14-3-3 proteins: integrators of diverse signaling cues that impact cell fate and cancer development. Trends Cell Biol 2009; 19: 16-23.
15. Fu H, Subramanian RR, Masters SC. 14-3-3 proteins: structure, function, and regulation. Annu Rev Pharmacol Toxicol 2000; 40: 617-647.
16. Tzivion G, Shen YH, Zhu J. 14-3-3 proteins; bringing new definitions to scaffolding. Oncogene 2001; 20: 6331-6338.
17. Wiltfang J, Otto M, Baxter HC, Bodemer M, Steinacker P, Bahn E et al. Isoform pattern of 14-3-3 proteins in the cerebrospinal fluid of patients with Creutzfeldt-Jakob disease. J Neurochem 1999; 73: 2485-2490.
18. Jayaratnam S, Khoo AK, Basic D. Rapidly progressive Alzheimer's disease and elevated 14-3-3 proteins in cerebrospinal fluid. Age Ageing 2008; 37: 467-469.
19. Yacoubian TA, Slone SR, Harrington AJ, Hamamichi S, Schieltz JM, Caldwell KA et al. Differential neuroprotective effects of 14-3-3 proteins in models of Parkinson's disease. Cell Death Dis 2010; 1: e2.
20. Chen XQ, Fung YW, Yu AC. Association of 14-3-3gamma and phosphorylated bad attenuates injury in ischemic astrocytes. J Cereb Blood Flow Metab 2005; 25: 338-347.
21. Chen XQ, Chen JG, Zhang Y, Hsiao WW, Yu AC. 14-3-3gamma is upregulated by in vitro ischemia and binds to protein kinase Raf in primary cultures of astrocytes. Glia 2003; 42: 315-324.
22. Umahara T, Uchihara T, Tsuchiya K, Nakamura A, Iwamoto T. Intranuclear localization and isoform-dependent translocation of 14-3-3 proteins in human brain with infarction. J Neurol Sci 2007; 260: 159-166.
23. Bose P, Thakur S, Thalappilly S, Ahn BY, Satpathy S, Feng X et al. ING1 induces apoptosis through direct effects at the mitochondria. Cell Death Dis 2013; 4: e837.
24. Zhao H, Shimohata T, Wang JQ, Sun G, Schaal DW, Sapolsky RM et al. Akt contributes to neuroprotection by hypothermia against cerebral ischemia in rats. J Neurosci 2005; 25: 9794-9806.
25. Xi L, Taher M, Yin C, Salloum F, Kukreja RC. Cobalt chloride induces delayed cardiac preconditioning in mice through selective activation of HIF-1alpha and AP-1 and iNOS signaling. Am J Physiol Heart Circ Physiol 2004; 287: H2369-H2375.
26. Valsecchi V, Pignataro G, Del Prete A, Sirabella R, Matrone C, Boscia F et al. NCX1 is a novel target gene for hypoxia-inducible factor-1 in ischemic brain preconditioning. Stroke 2011; 42: 754-763.
27. Mhawech P. 14-3-3 proteins-an update. Cell Res 2005; 15: 228-236.
28. Nomura M, Shimizu S, Sugiyama T, Narita M, Ito T, Matsuda H et al. 14-3-3 interacts directly with and negatively regulates pro-apoptotic Bax. J Biol Chem 2003; 278: 2058-2065.
29. Zha J, Harada H, Yang E, Jockel J, Korsmeyer SJ. Serine phosphorylation of death agonist BAD in response to survival factor results in binding to 14-3-3 not BCL-X(L). Cell 1996; 87: 619-628.
30. Krieghoff E, Behrens J, Mayr B. Nucleo-cytoplasmic distribution of beta-catenin is regulated by retention. J Cell Sci 2006; 119(Pt 7): 1453-1463.
31. Wodarz A, Nusse R. Mechanisms ofWnt signaling in development. Annu Rev Cell Dev Biol 1998; 14: 59-88.
32. Klaus A, Birchmeier W. Wnt signalling and its impact on development and cancer. Nat Rev Cancer 2008; 8: 387-398.
33. Saikumar P, Dong Z, Weinberg JM, Venkatachalam MA. Mechanisms of cell death in hypoxia/reoxygenation injury. Oncogene 1998; 17: 3341-3349.
34. Lin CH, Lu YZ, Cheng FC, Chu LF, Hsueh CM. Bax-regulated mitochondria-mediated apoptosis is responsible for the in vitro ischemia induced neuronal cell death of Sprague Dawley rat. Neurosci Lett 2005; 387: 22-27.
35. Wang Z, Gall JM, Bonegio R, Havasi A, Illanes K, Schwartz JH et al. Nucleophosmin, a critical Bax cofactor in ischemia-induced cell death. Mol Cell Biol 2013; 33: 1916-1924.
36. Tian Q, Feetham MC, Tao WA, He XC, Li L, Aebersold R et al. Proteomic analysis identifies that 14-3-3zeta interacts with beta-catenin and facilitates its activation by Akt. Proc Natl Acad Sci USA 2004; 101: 15370-15375.
37. Cappuccio I, Calderone A, Busceti CL, Biagioni F, Pontarelli F, Bruno V et al. Induction of Dickkopf-1, a negative modulator of the Wnt pathway, is required for the development of ischemic neuronal death. J Neurosci 2005; 25: 2647-2657.
38. Puyal J, Ginet V, Clarke PG. Multiple interacting cell death mechanisms in the mediation of excitotoxicity and ischemic brain damage: a challenge for neuroprotection. Prog Neurobiol 2013; 105: 24-48.
39. Benchoua A, Guégan C, Couriaud C, Hosseini H, Sampaïo N, Morin D et al. Specific caspase pathways are activated in the two stages of cerebral infarction. J Neurosci 2001; 21: 7127-7134.
40. Sun M, Zhao Y, Xu C. Cross-talk between calpain and caspase-3 in penumbra and core during focal cerebral ischemia-reperfusion. Cell Mol Neurobiol 2008; 28: 71-85.
41. Ye SQ, Zhou XY, Lai XJ, Zheng L, Chen XQ. Silencing neuroglobin enhances neuronal vulnerability to oxidative injury by down-regulating 14-3-3gamma. Acta Pharmacol Sin 2009; 30: 913-918.
42. Li L, Liu QR, Xiong XX, Liu JM, Lai XJ, Cheng C et al. Neuroglobin promotes neurite outgrowth via differential binding to PTEN and Akt. Mol Neurobiol 2014; 49: 149-162.
43. Zhang J, Lan SJ, Liu QR, Liu JM, Chen XQ. Neuroglobin a novel intracellular hexa-coordinated globin, functions as a tumor suppressor in hepatocellular carcinoma via Raf/MAPK/Erk. Mol Pharmacol 2013; 83: 1109-1119.
44. Li Y, Chopp M, Jiang N, Yao F, Zaloga CJ. Temporal profile of in situ DNA fragmentation after transient middle cerebral artery occlusion in the rat. J Cereb Blood Flow Metab 1995; 15: 389-397.
45. Cheng J, Uchida M, Zhang W, Grafe MR, Herson PS, Hurn PD. Role of salt-induced kinase 1 in androgen neuroprotection against cerebral ischemia. J Cereb Blood Flow Metab 2011; 31: 339-350.
46. Hu S, Yang H, Cai R, Liu Z, Yang X. Biotin induced fluorescence enhancement in resonance energy transfer and application for bioassay. Talanta 2009; 80: 454-458.